• Users Online: 25
  • Print this page
  • Email this page
Year : 2022  |  Volume : 18  |  Issue : 4  |  Page : 217-220

Need for artificial intelligence in pharmaceutical industry and its limitations

Department of Pharmacology, Rajasthan University of Health Sciences, College of Medical Sciences, Jaipur, Rajasthan, India

Correspondence Address:
Dr. Varun Pareek
K101 Plot 173-174 Kushmanda Apt., Kishan Nagar, Shyam Nagar, Jaipur - 302 019, Rajasthan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jiag.jiag_33_22

Rights and Permissions

Artificial intelligence (AI) is often being touted as the means to bring about the fourth industrial revolution and its role in almost all sectors of our society is almost certain. This brings about an urgent need for evaluating the benefits and limitations of AI and machine learning (ML) across various sectors. Pharmaceutical industry has pioneered in embracing the use of AI in all its core areas but the success as of now seems very limited. The major advantage of AI is that it reduces the time that is needed for drug development, and in turn, it reduces the costs that are associated with drug development, enhances the returns on investment, and may even cause a decrease in cost for the end user along with improved drug safety. Hence, in this article, we will review the scope and limitations of AI in the pharmaceutical industry along with the brief review of how AI/ML can impact geriatric health care.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded20    
    Comments [Add]    

Recommend this journal